Your session is about to expire
← Back to Search
Cipherome Lighthouse Pilot for Blood Clot (CARES2 Trial)
N/A
Waitlist Available
Led By Herschl Silberman, MD
Research Sponsored by Cipherome, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up study pilot duration is 365 days (1 year)
Awards & highlights
CARES2 Trial Summary
This trial aims to test whether the use of Cipherome's Lighthouse can improve patient outcomes.
Eligible Conditions
- Blood Clot
- Ischemic Stroke
- Heart Attack
- Stent Thrombosis
- Stroke
- Bleeding
CARES2 Trial Timeline
Screening ~ 3 weeks3 visits
Treatment ~ Varies
Follow Up ~ study pilot duration is 365 days (1 year)
Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~study pilot duration is 365 days (1 year)
Treatment Details
Study Objectives
Outcome measures can provide a clearer picture of what you can expect from a treatment.Primary outcome measures
Evaluation of aggregate costs
Secondary outcome measures
Reduction of major or minor bleeding events
Reduction of treatment failures
Other outcome measures
Assessment of the correlation of clinical factors (age, labs, medications) on predicting and preventing adverse drug reactions
CARES2 Trial Design
2Treatment groups
Experimental Treatment
Active Control
Group I: Genotype-guided therapy (experimental)Experimental Treatment1 Intervention
Treatment with clopidogrel 75 mg daily for non-carriers
Treatment with ticagrelor 90 mg twice daily for carriers
Group II: Conventional Therapy (Controls)Active Control1 Intervention
Treatment with clopidogrel and no pre-emptive genotyping
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Cipherome Lighthouse Pilot
2020
N/A
~300
Find a Location
Who is running the clinical trial?
Cipherome, Inc.Lead Sponsor
6 Previous Clinical Trials
893 Total Patients Enrolled
DHR Health Institute for Research and DevelopmentOTHER
11 Previous Clinical Trials
4,046 Total Patients Enrolled
Herschl Silberman, MDPrincipal InvestigatorDHR Health
Frequently Asked Questions
These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.
Are individuals still being recruited for participation in the research?
"Affirmative. The information on clinicaltrials.gov reveals that this trial is actively recruiting, first posted on December 3rd 2020 and last updated July 18th 2022. Currently, 300 people are needed to be recruited from a single site."
Answered by AI
How many people have enrolled in this research project?
"Affirmative. The clinical trial is currently enrolling participants, as indicated on clinicaltrials.gov; it was first posted on December 3rd 2020 and the most recent update was made on July 18th 2022. 300 individuals are needed from one medical site to take part in this study."
Answered by AI
Recent research and studies
Other Trials to Consider
Popular Categories
Share this study with friends
Copy Link
Messenger